US/UK/Canada

Share

Pick a time period -
Tags ( Active)

AlzeCure publishes its interrim report for Q1 2019

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its interrim report for the first quarter of 2019 is now available on the company’s website: https://www.alzecurepharma.se/sv/section/investerare/finansiella-rapporter/Financial information for the first quarter, 2019 · Net sales during the period amounted to SEK 0 thousand (0). · Earnings after financial items amounted to SEK -11,586 thousand (-9,624). · Earnings per share before and after dilution amounted to SEK -0.31 (-0.51). · The balance sheet total amounted to SEK 225,876 thousand (46,669) as of 3/31/2019.

AlzeCure publishes prospectus prior to listing on Nasdaq First North Premier

THIS PRESS RELEASE WAS ORIGINALLY RELEASED IN SWEDISH FOR THE SWEDISH MARKET AND HAS LATER BEEN TRANLSATED TO ENGLISH FOR GENERAL AWARENESS ON THE GLOBAL MARKET. NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE OR REPUBLIC OF SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. OTHER RESTRICTIONS ARE APPLICABLE, PLEASE REFER TO “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE.AlzeCure Pharma AB (“

AlzeCure to present data from its two main projects at the 10th annual Conference on Clinical Trials for Alzheimer’s Disease (CTAD)

Stockholm, Sweden, October 19, 2017 - AlzeCure Pharma (AlzeCure) today announced that data from its two main projects – NeuroRestore and Alzstatin – will be presented at the 10th annual Conference on Clinical Trials for Alzheimer’s Disease (CTAD) in Boston, MA, USA on November 1 - 4, 2017.All presentations are submitted to a scientific committee and those approved will be able to present their findings, which has to be original data or reinterpretation of data in light of new clinical results. The NeuroRestore project, currently in preclinical development, will be presented by Dr. Pontus

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe